Annual Working Capital
$16.07 M
+$2.44 M+17.92%
December 31, 2023
Summary
- As of February 12, 2025, IMMX annual working capital is $16.07 million, with the most recent change of +$2.44 million (+17.92%) on December 31, 2023.
- During the last 3 years, IMMX annual working capital has risen by +$20.80 million (+439.09%).
- IMMX annual working capital is now -10.67% below its all-time high of $17.98 million, reached on December 31, 2021.
Performance
IMMX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$16.19 M
-$7.24 M-30.89%
September 30, 2024
Summary
- As of February 12, 2025, IMMX quarterly working capital is $16.19 million, with the most recent change of -$7.24 million (-30.89%) on September 30, 2024.
- Over the past year, IMMX quarterly working capital has dropped by -$3.31 million (-16.99%).
- IMMX quarterly working capital is now -40.60% below its all-time high of $27.26 million, reached on March 31, 2024.
Performance
IMMX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IMMX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.9% | -17.0% |
| 3 y3 years | +439.1% | -17.0% |
| 5 y5 years | +539.4% | -17.0% |
IMMX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.7% | +17.9% | -40.6% | +40.1% |
| 5 y | 5-year | -10.7% | +439.1% | -40.6% | +360.3% |
| alltime | all time | -10.7% | +439.1% | -40.6% | +360.3% |
Immix Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.19 M(-30.9%) |
| Jun 2024 | - | $23.43 M(-14.0%) |
| Mar 2024 | - | $27.26 M(+69.7%) |
| Dec 2023 | $16.07 M(+17.9%) | $16.07 M(-17.6%) |
| Sep 2023 | - | $19.51 M(+48.8%) |
| Jun 2023 | - | $13.11 M(+13.4%) |
| Mar 2023 | - | $11.56 M(-15.1%) |
| Dec 2022 | $13.62 M | $13.62 M(-18.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $16.74 M(-7.5%) |
| Jun 2022 | - | $18.11 M(-7.8%) |
| Mar 2022 | - | $19.65 M(+9.2%) |
| Dec 2021 | $17.98 M(-479.6%) | $17.98 M(-389.1%) |
| Sep 2021 | - | -$6.22 M(+9.1%) |
| Jun 2021 | - | -$5.70 M(+20.4%) |
| Dec 2020 | -$4.74 M(+29.6%) | -$4.74 M |
| Dec 2019 | -$3.66 M | - |
FAQ
- What is Immix Biopharma annual working capital?
- What is the all time high annual working capital for Immix Biopharma?
- What is Immix Biopharma annual working capital year-on-year change?
- What is Immix Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Immix Biopharma?
- What is Immix Biopharma quarterly working capital year-on-year change?
What is Immix Biopharma annual working capital?
The current annual working capital of IMMX is $16.07 M
What is the all time high annual working capital for Immix Biopharma?
Immix Biopharma all-time high annual working capital is $17.98 M
What is Immix Biopharma annual working capital year-on-year change?
Over the past year, IMMX annual working capital has changed by +$2.44 M (+17.92%)
What is Immix Biopharma quarterly working capital?
The current quarterly working capital of IMMX is $16.19 M
What is the all time high quarterly working capital for Immix Biopharma?
Immix Biopharma all-time high quarterly working capital is $27.26 M
What is Immix Biopharma quarterly working capital year-on-year change?
Over the past year, IMMX quarterly working capital has changed by -$3.31 M (-16.99%)